Michael J. LaBarre - 13 Dec 2022 Form 4 Insider Report for HALOZYME THERAPEUTICS, INC. (HALO)

Role
SVP, CHIEF TECHNICAL OFFICER
Signature
/s/ James R. Oehler, Attorney-in-Fact
Issuer symbol
HALO
Transactions as of
13 Dec 2022
Net transactions value
-$586,675
Form type
4
Filing time
13 Dec 2022, 17:09:50 UTC
Previous filing
16 Nov 2022
Next filing
18 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HALO Common Stock Sale $289,541 -4,935 -3% $58.67 158,202 13 Dec 2022 Direct F1, F2
transaction HALO Common Stock Sale $297,133 -5,065 -3.2% $58.66 153,137 13 Dec 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This disposition was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person
F2 Represents a weighted average sales price per share. These shares were sold at prices ranging from $58.233 to $59.12. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.